Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. - Wikidata - awgldk - TriplyDB

Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity.

Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity.

http://www.wikidata.org/entity/Q41808826

about

Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis [Methotrexate toxicity. Myths and facts].Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies.C677T (RS1801133 ) MTHFR gene polymorphism frequency in a colombian population.Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies.Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.Rheumatoid arthritis pharmacogenomics.Pharmacogenetics of psoriasis.Hepatotoxicity related to antirheumatic drugs.Pharmacogenetics: implications for therapy in rheumatic diseases.Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.Susceptibility genes and pharmacogenetics in ocular inflammatory disorders.Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort.Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.A case of recurrent pancytopenia in a patient with acute promyelocytic leukemia on maintenance chemotherapy and concomitant methyltetrahydrofolate reductase and thiopurine S-methyltransferase mutation - review of literature.Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.Identifying Common Genetic Risk Factors of Diabetic Neuropathies.Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis.Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta-analysis.The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.A personal journey from the joint to the heart.Role of interactions in pharmacogenetic studies: leukotrienes in asthma.MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms.Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.Do impaired memory, cognitive dysfunction and distress play a role in methotrexate-related neutropenia in rheumatoid arthritis patients? A comparative study.MTHFR functional genetic variation and methotrexate treatment response in rheumatoid arthritis: a meta-analysis.The C677T polymorphism in theMTHFRgene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population

P2860

Q26995202-3DA73470-3066-4F1D-8796-24893584945A Q28394552-ED38F34E-73F1-4482-A868-7F1344FDDC18 Q30318490-D16C0705-E21C-418A-93BE-F665D645392A Q33654733-2379060D-1844-4FDC-8BBE-534B89C777AC Q33845138-A8AEBEC3-6464-4147-BEBD-04CD7DB733D6 Q34320780-5AFA55F7-5130-4207-94AA-302243F757F1 Q35147847-7442401F-3BC1-4651-87A9-3E8C8653A2EB Q35159896-47CA8227-28A5-41B3-8BAD-79C6E929FCE6 Q35954562-8E0A21A0-3941-46E0-9F08-A16583E08B16 Q36441438-8865A563-8783-451C-81A7-0719EF932F26 Q37683906-342CFA93-2724-428D-86FE-94F199D2E44C Q37725354-AE5A274B-070D-47DA-901F-4194E22AC622 Q37736447-EFF2AC68-E1CF-412A-97AA-156762A44A61 Q37822759-2AB47713-158F-4420-BC8F-AC260DFBC41B Q37832129-82FB0429-C84D-4298-843B-A9B201077421 Q37913989-BD0326B2-1E7F-4737-A78D-ADE91008A486 Q37946958-3D3E2285-A95B-4936-B42D-0637E56E9DCE Q38043013-4C171B6A-D371-470A-BBDF-592ED5BD8D1C Q38068540-1520F73E-5BB5-4777-962D-A11EB9C58120 Q38080147-19CC3603-24D3-46C8-9121-9CAFEF6E6FED Q38084444-D7CBC5F9-E05D-49EE-9CA6-CDECC8A897F4 Q38194466-FBD2C655-6D23-4B8A-B9AB-CCF19D382859 Q38195630-79E1C119-0422-410C-BE48-47290D48CE4D Q38384376-A61900ED-9A6F-4DE0-8264-E0DD793D26A2 Q38416696-D244EBC3-3ABB-4984-BBB8-9531526BB322 Q38495339-653B53EC-C987-41F9-B655-2D583544587B Q38527798-DA727F0F-7103-485B-8305-D7CD5F760B25 Q38936379-08C3E8EB-5E2A-41C2-AF50-AD9771240799 Q39043220-5F9528C2-7E5E-4D8D-B625-A01E60F0310E Q39330126-111703A6-D1A2-414F-A00F-E7432DD1342D Q41530781-9A114C7D-7CF0-4DEF-ABBE-626B405EAA97 Q42420333-FC11AEA3-59D1-4818-B13C-E430BE285903 Q42843908-5AFAD516-FAD1-4027-AF5D-C102967EB9FD Q44539907-74E9BC72-5E75-44DE-8722-DD1F8AABBC05 Q44621683-33E3FA37-4F57-4715-9241-049610B805DF Q45399424-CDC12C1C-3BBA-4958-97CD-D2BFD026B2B2 Q52840082-3514C27E-B278-4247-91F1-B24902C373F0 Q58912366-2802D742-30B5-4E9A-A454-6CB57A5DFB3E

P2860

Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity.

http://www.wikidata.org/entity/Q41808826

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Metaanalysis of methylenetetra ...... fecting methotrexate toxicity.

@en

type

label

Metaanalysis of methylenetetra ...... fecting methotrexate toxicity.

@en

prefLabel

Metaanalysis of methylenetetra ...... fecting methotrexate toxicity.

@en

P1433

Q41808826-D9C5CEE6-09B4-4B34-9B4A-87E7AD91A32D

P1476

Q41808826-A85329DF-25E5-4760-8EC7-55EC01A807F0

P2093

Q41808826-008C58F6-1E5E-4FBA-9B85-2E76D7EF46DA

Q41808826-C4AF8AB7-B58E-4746-8844-4D01F622D936

P2860

Q41808826-0133BEB0-4DE1-414C-9337-718F7549AAB4

Q41808826-035C8C66-F603-4238-BA24-FDB6E79CE169

Q41808826-09AF51B5-E564-403B-9702-79E65880F9EA

Q41808826-1C2157FD-92FA-4927-975B-115B313D2FF1

Q41808826-2DD3FAFA-A0D5-49D4-88AA-375F9B37E8BB

Q41808826-2E0F69B5-BB07-4979-A938-742763DF6047

Q41808826-3B81B37A-62BD-4399-BEF0-62966E21E5CC

Q41808826-4784D9BB-E5B0-47E0-AD12-8090822BD733

Q41808826-47ECC7BF-A111-4C79-924F-7035783FE0D1

Q41808826-4CF2D0D6-1FB4-4D0D-BA20-377102EAF90A

P304

Q41808826-B4CA37BB-039C-437A-AC07-35C2AC5270B2

P31

Q41808826-7b74b0d8-eab9-4869-9359-5718c69b1ce1

Q41808826-D35D3458-3112-41D0-B39C-672FD7F38E7E

P356

Q41808826-194C7B51-CB3B-42F4-BDD4-ECBC941CF40C

P407

Q41808826-22954825-4B3F-414B-A819-FB10676B839E

P433

Q41808826-E8342685-0EF0-4CCC-A082-6A4706AD1FB3

P478

Q41808826-701C938E-06B1-4682-9EBF-D9A3B06B2B49

P577

Q41808826-DD49A800-4F15-447D-8854-DC056E69EBF8

P5875

Q41808826-C832AAED-C8D9-4DEF-998A-4C6095B4283A

P698

Q41808826-CBB30AE2-8CB8-473C-AE5C-163BA81D2CE9

P932

Q41808826-B94E7516-0604-4994-9D8E-156EE9CA219F

P356

P1433

The Journal of Rheumatology

P1476

Metaanalysis of methylenetetra ...... fecting methotrexate toxicity.

@en

P2093

Bruce N Cronstein

http://www.w3.org/2001/XMLSchema#string

Mark C Fisher

http://www.w3.org/2001/XMLSchema#string

P2860

A comprehensive review of genetic association studies

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

Biological and clinical implications of the MTHFR C677T polymorphism.

Folate, methyl-related nutrients, alcohol, and the MTHFR 677C-->T polymorphism affect cancer risk: intake recommendations.

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.

Methotrexate hepatotoxicity.

Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?

5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview.

Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene

P304

539-545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3899/JRHEUM.080576

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23999024

http://www.w3.org/2001/XMLSchema#string

P698

19208607

http://www.w3.org/2001/XMLSchema#string

P932

2673494

http://www.w3.org/2001/XMLSchema#string